![Michael Rosol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Rosol
Keine laufenden Positionen mehr
Profil
Michael S.
Rosol's former jobs include Chief Executive Officer at Atherion Bioresearch, Inc., Senior Director-Business Development at Elucid Bioimaging, Inc. in 2016, Associate Director-Clinical & Translational at Novartis Institutes for Biomedical Research, Inc. from 2016 to 2018, Chief Medical Officer & Senior Vice President at Navidea Biopharmaceuticals, Inc. from 2018 to 2023, Head-Translational Imaging Group at Novartis Pharmaceuticals Corp.
from 2012 to 2015, Chief Scientific Officer at Medilumine, Inc. from 2015 to 2016, and Chief Development Officer at Plus Therapeutics, Inc. from 2025 to 2026.
Education includes a doctorate from Boston University School of Medicine.
Ehemalige bekannte Positionen von Michael Rosol
| Unternehmen | Position | Ende |
|---|---|---|
| CERENOME, INC. | Corporate Officer/Principal | 20.04.2026 |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.03.2023 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01.12.2018 |
Elucid Bioimaging, Inc.
 Elucid Bioimaging, Inc. Packaged SoftwareTechnology Services Operates as an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient | Corporate Officer/Principal | 01.11.2016 |
Medilumine, Inc. | Corporate Officer/Principal | 01.05.2016 |
Ausbildung von Michael Rosol
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Navidea Biopharmaceuticals, Inc.
 Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Packaged SoftwareTechnology Services Operates as an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient | Technology Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medilumine, Inc. |
